U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 461

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr19:46087983
GRCh38:
Chr19:45584725
OPA3L14V3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Jun 23, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr19:46056854
GRCh38:
Chr19:45553596
OPA3R153L3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Apr 4, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr19:46056888-46056889
GRCh38:
Chr19:45553630-45553631
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Sep 12, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr19:46087989
GRCh38:
Chr19:45584731
OPA3L12V3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(May 11, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr19:46057023
GRCh38:
Chr19:45553765
OPA3L97V3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Aug 1, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr19:46087908
GRCh38:
Chr19:45584650
OPA3T39A3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Aug 11, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr19:46057160
GRCh38:
Chr19:45553902
OPA3W51*3-Methylglutaconic aciduria type 3, Optic atrophy 3Likely pathogenic
(Sep 27, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr19:46056875
GRCh38:
Chr19:45553617
OPA3Q146R3-Methylglutaconic aciduria type 3, Optic atrophy 3, Inborn genetic diseases
Uncertain significance
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr19:46087999
GRCh38:
Chr19:45584741
OPA3M8IInborn genetic diseases, 3-Methylglutaconic aciduria type 3, Optic atrophy 3
Uncertain significance
(Sep 7, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr19:46087861
GRCh38:
Chr19:45584603
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Oct 1, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr19:46057087
GRCh38:
Chr19:45553829
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Sep 26, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr19:46056960
GRCh38:
Chr19:45553702
OPA3A118P3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Sep 26, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr19:46056895
GRCh38:
Chr19:45553637
OPA3Q139H3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(May 4, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr19:46057092
GRCh38:
Chr19:45553834
OPA3E74*3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Sep 13, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr19:46087902
GRCh38:
Chr19:45584644
OPA3I41V3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Sep 15, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr19:46057186
GRCh38:
Chr19:45553928
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(May 27, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr19:46056975
GRCh38:
Chr19:45553717
OPA3E113K3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Oct 13, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr19:46056864
GRCh38:
Chr19:45553606
OPA3E150Q3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Oct 22, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr19:46057102
GRCh38:
Chr19:45553844
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Jul 16, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr19:46087978
GRCh38:
Chr19:45584720
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Sep 12, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr19:46056878
GRCh38:
Chr19:45553620
OPA3P145L3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Aug 24, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr19:46056952
GRCh38:
Chr19:45553694
OPA3N120K3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(May 5, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr19:46056799
GRCh38:
Chr19:45553541
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Aug 4, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr19:46087920
GRCh38:
Chr19:45584662
OPA3E35*3-Methylglutaconic aciduria type 3, Optic atrophy 3Pathogenic
(Apr 21, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr19:46057065
GRCh38:
Chr19:45553807
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Sep 13, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr19:46056939
GRCh38:
Chr19:45553681
OPA3E125Q3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Jul 31, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr19:46087939
GRCh38:
Chr19:45584681
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Jun 12, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr19:46057084
GRCh38:
Chr19:45553826
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Apr 4, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr19:46087891
GRCh38:
Chr19:45584633
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Feb 28, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr19:46056932
GRCh38:
Chr19:45553674
OPA3G127D3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Feb 18, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr19:46088008
GRCh38:
Chr19:45584750
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Feb 17, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr19:46087934
GRCh38:
Chr19:45584676
OPA3A30V3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Feb 14, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr19:46087887
GRCh38:
Chr19:45584629
OPA3A46T3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Feb 5, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr19:46056970
GRCh38:
Chr19:45553712
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Jan 15, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr19:46056835
GRCh38:
Chr19:45553577
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Jan 15, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr19:46056828
GRCh38:
Chr19:45553570
OPA3Q162*3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Jul 25, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr19:46057008
GRCh38:
Chr19:45553750
OPA3W102G3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Jan 11, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr19:46056857
GRCh38:
Chr19:45553599
OPA3L152P3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Aug 16, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr19:46087998
GRCh38:
Chr19:45584740
OPA3A9T3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Aug 22, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr19:46056818
GRCh38:
Chr19:45553560
OPA3N165S3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Aug 16, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr19:46057074
GRCh38:
Chr19:45553816
OPA3G80S3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Sep 26, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr19:46057178
GRCh38:
Chr19:45553920
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Oct 3, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr19:46057108
GRCh38:
Chr19:45553850
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Sep 7, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr19:46056948
GRCh38:
Chr19:45553690
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Sep 2, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr19:46057173
GRCh38:
Chr19:45553915
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Aug 11, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr19:46056850
GRCh38:
Chr19:45553592
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Aug 5, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr19:46056835
GRCh38:
Chr19:45553577
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Jul 23, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr19:46057059
GRCh38:
Chr19:45553801
OPA3G85R3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Jul 4, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr19:46057117
GRCh38:
Chr19:45553859
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Jun 3, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr19:46056882-46056883
GRCh38:
Chr19:45553624-45553625
OPA3P144T3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(May 27, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr19:46056795
GRCh38:
Chr19:45553537
OPA3A173T3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(May 21, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr19:46056876
GRCh38:
Chr19:45553618
OPA3Q146K3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Sep 13, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr19:46057068
GRCh38:
Chr19:45553810
OPA3E82*3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Sep 13, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr19:46056920
GRCh38:
Chr19:45553662
OPA3L131Q3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Aug 22, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr19:46057147
GRCh38:
Chr19:45553889
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Jul 26, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr19:46087912
GRCh38:
Chr19:45584654
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Apr 28, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr19:46057047
GRCh38:
Chr19:45553789
OPA3I89V3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(May 8, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr19:46056938
GRCh38:
Chr19:45553680
OPA3E125V3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Sep 27, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr19:46056843
GRCh38:
Chr19:45553585
OPA3Q157E3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Apr 11, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr19:46087942
GRCh38:
Chr19:45584684
OPA3K28fs3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Sep 13, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr19:46056840
GRCh38:
Chr19:45553582
OPA3E158K3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Dec 19, 2021)
criteria provided, single submitter
62.
GRCh37:
Chr19:46087868
GRCh38:
Chr19:45584610
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Apr 28, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr19:46056926-46056927
GRCh38:
Chr19:45553668-45553669
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Sep 4, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr19:46087929
GRCh38:
Chr19:45584671
OPA3R32C3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Jun 10, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr19:46057111
GRCh38:
Chr19:45553853
OPA3I68fs3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Sep 13, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr19:46057170
GRCh38:
Chr19:45553912
OPA33-Methylglutaconic aciduria type 3Pathogeniccriteria provided, single submitter
67.
GRCh37:
Chr19:46057170-46088123
OPA33-Methylglutaconic aciduria type 3Likely pathogenic
(Oct 3, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr19:46087993
GRCh38:
Chr19:45584735
OPA3K10N3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Jul 22, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr19:46057100
GRCh38:
Chr19:45553842
OPA3L71P3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Sep 9, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr19:46087932
GRCh38:
Chr19:45584674
OPA3A31P3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Aug 17, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr19:46087950
GRCh38:
Chr19:45584692
OPA3N25D3-Methylglutaconic aciduria type 3, Optic atrophy 3Uncertain significance
(Jul 30, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr19:46056881
GRCh38:
Chr19:45553623
OPA3P144R3-Methylglutaconic aciduria type 3, Optic atrophy 3, Optic atrophy 3
Uncertain significance
(Feb 24, 2022)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr19:46057177
GRCh38:
Chr19:45553919
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Jul 15, 2021)
criteria provided, single submitter
74.
GRCh37:
Chr19:46056781
GRCh38:
Chr19:45553523
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(May 18, 2021)
criteria provided, single submitter
75.
GRCh37:
Chr19:46087993
GRCh38:
Chr19:45584735
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Jan 11, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr19:46056859
GRCh38:
Chr19:45553601
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Jun 18, 2021)
criteria provided, single submitter
77.
GRCh37:
Chr19:46057077
GRCh38:
Chr19:45553819
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Jul 19, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr19:46056949
GRCh38:
Chr19:45553691
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Aug 15, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr19:46087863
GRCh38:
Chr19:45584605
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Dec 2, 2020)
criteria provided, single submitter
80.
GRCh37:
Chr19:46057168
GRCh38:
Chr19:45553910
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Apr 24, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr19:46056850
GRCh38:
Chr19:45553592
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Jul 18, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr19:46056979
GRCh38:
Chr19:45553721
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Oct 14, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr19:46057075
GRCh38:
Chr19:45553817
OPA3Optic atrophy 3, 3-Methylglutaconic aciduria type 3Likely benign
(Mar 24, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr19:46056796
GRCh38:
Chr19:45553538
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Aug 4, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr19:46087865
GRCh38:
Chr19:45584607
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Jun 27, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr19:46056871
GRCh38:
Chr19:45553613
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Aug 21, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr19:46087871
GRCh38:
Chr19:45584613
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Sep 27, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr19:46056805
GRCh38:
Chr19:45553547
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Nov 19, 2021)
criteria provided, single submitter
89.
GRCh37:
Chr19:46057030
GRCh38:
Chr19:45553772
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Oct 13, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr19:46057057
GRCh38:
Chr19:45553799
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Oct 12, 2021)
criteria provided, single submitter
91.
GRCh37:
Chr19:46056961
GRCh38:
Chr19:45553703
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Jun 14, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr19:46057178
GRCh38:
Chr19:45553920
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Nov 1, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr19:46056886
GRCh38:
Chr19:45553628
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Nov 18, 2021)
criteria provided, single submitter
94.
GRCh37:
Chr19:46056949
GRCh38:
Chr19:45553691
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Aug 29, 2021)
criteria provided, single submitter
95.
GRCh37:
Chr19:46056985
GRCh38:
Chr19:45553727
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Nov 27, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr19:46087951
GRCh38:
Chr19:45584693
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Oct 7, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr19:46088017
GRCh38:
Chr19:45584759
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Dec 25, 2021)
criteria provided, single submitter
98.
GRCh37:
Chr19:46057009
GRCh38:
Chr19:45553751
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Dec 22, 2020)
criteria provided, single submitter
99.
GRCh37:
Chr19:46057066
GRCh38:
Chr19:45553808
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Oct 27, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr19:46087983
GRCh38:
Chr19:45584725
OPA33-Methylglutaconic aciduria type 3, Optic atrophy 3Likely benign
(Sep 1, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination